dc.description.abstract |
Obesity is a global public health problem of 21 st century. Recent surveys show that the
incidence of obesity has reached epidemic proportions in the world and its rate is increasing
both in children and adults. It is a multi-factorial and heterogeneous condition due to complex
interaction between genetic, behavioral and environmental factors. Recent reports suggest
that the genetic factors play an important role in the development of obesity. A number of
genetic variants in different genes have been reported to be associated with obesity in various
populations.
The current study was carried out to gain an insight into the role of fat mass and obesity
associated gene (FTO), leptin receptor (LEPR) and leptin (LEP) gene variants in the
pathophysiology of obesity in local population. A total of 394 subjects (obese=239, BMI
≥30Kg/m 2 or 95 th percentile and non-obese=155, BMI<25Kg/m 2 or 5 th -85 th percentile)
between 5-45yrs of age were analyzed for Q223R, G2548A and rs9939609 variants of LEPR,
LEP and FTO genes respectively, and their association with anthropometric and metabolic
parameters was determined. Body weight, height, waist and hip circumference and blood
pressure (BP) were measured, BMI and Waist Hip Ratio (WHR) were determined. Fasting
blood glucose (FBG), insulin, leptin and leptin receptors were measured in duplicate using
ELISA and HOMA-IR was calculated. DNA was extracted from the whole blood; genotyping
of the polymorphisms were carried out by polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP). Data were analyzed using SPSS version 17; parameters
were compared using t-test, one way ANOVA, Tukey post hoc test, Pearson test, Chi-square
test, general linear model (GLM) multivariate analysis and Hardy Weinberg equilibrium test.
In the present study LEP G2548A polymorphism was found to be associated with obesity in
female children and adolescents (≤18years of age). Female children and adolescents carrying
G allele of G2548A polymorphism were found to have 2.23 times increased risk of obesity in
(95% CI=1.07–4.63). G allele of G2548A polymorphism was found to be associated with
increased body weight, height, BMI, hip circumference, WHR, HOMA-IR, plasma insulin
and leptin levels. No significant difference was found in genotype and allele frequencies of
LEPR Q223R polymorphism between obese and non obese subjects. No association of LEPR
Q223R polymorphism was observed with any of the anthropometric and metabolic traits
related to obesity. FTO rs9939609 variant was found to be associated with obesity in adult
females (>18years of age). Women carrying A allele of this polymorphism were found to
have 2.81 times increased risk of obesity (95% CI=1.31-6.04). A allele was found to be
xiiiassociated with increase in body weight, BMI, waist and hip circumference, WHR, BP, FBG,
HOMA-IR, plasma insulin and leptin levels and decrease in leptin receptor levels.
LEP (G2548A) variant is an important predictor for increased plasma leptin and BMI among
female children and adolescents. FTO (rs9939609) variant is associated with BMI and risk of
obesity in adult females, carrier of A allele had higher FBG, HOMA-IR and leptin levels
independent of BMI. |
en_US |